Feature | April 19, 2011

CT Angiography Field Proactive With Significant Radiation Reduction

April 19, 2011 – Andrew Einstein delivered the Douglas P. Zipes Distinguished Young Scientist Award Lecture entitled "Effects of Radiation Exposure During Cardiac Imaging: How Good Is the Data?" at this year's American College of Cardiology annual scientific sessions. The field of cardiac computed tomography (CT) angiography has been proactive and responsible in developing and employing significant radiation sparing techniques in response to the concerns raised by Einstein and others.

The Society of Cardiovascular Computed Tomography (SCCT) considers radiation exposure during imaging a matter of utmost importance and supports the tremendous amount of work by vendors and clinicians to reduce unnecessary radiation exposure from diagnostic cardiac CT angiography. Firstly, the SCCT verification program supports the rigorous published cardiac CT training guidelines, which mandate extensive education in radiation safety and radiation reduction techniques for all Level II and Level III certified clinicians. In fact, radiation exposure from cardiac CT has been reduced by about 80 percent (15 mSv to 3-4 mSv) through advances in technology, protocols and algorithms, especially within the last two or three years. The average radiation exposure dose for cardiac CT angiography is now equal to and often less than that of invasive diagnostic cardiac angiography and is substantially lower than that of cardiac SPECT (single photon emission computed tomography) and PET (positron emission tomography) imaging. Published reports document radiation doses for common cardiac diagnostic tests as follows: prospective (state of the art) CT angiography protocols: 2-4 mSv; retrospective (older) CT angiography protocols: 12-18 mSv; diagnostic invasive coronary angiography: 7 mSv. SPECT perfusion studies: 12 mS; average annual background radiation exposures (United States): 3 mSv.

A 2010 article by Raff et al entitled "Radiation dose from coronary CT angiography: Five years of progress (published in the Journal of Cardiovascular Computed Tomography, Vol. 4, No. 6, November/December 2010) demonstrates the significant radiation reductions resulting from advances in the field. This point is illustrated by the following figure from his article (reproduced with the permission of Elsevier (Copyright Elsevier 2010).

Figure 1 (B) Radiation dose by year. Blue symbols indicate research reports by publication date; blue line, linear regression of reported research doses; red squares, multicenter clinical reported doses listed by year data collected; red line, linear regression of reported clinical survey doses.

In addition, preliminary data suggest that cardiac CT angiography may reduce the number of unnecessary SPECT and invasive angiographic studies. The SCCT also supports the inclusion of radiation dose reporting in the same document as the clinical report.

Further work in this area is ongoing and there have been more recent publications, including abstracts at these very scientific sessions, documenting the effectiveness of these radiation-sparing techniques.

The SCCT recommends that diagnostic radiation be utilized judiciously, in line with the principles of ALARA (as low as reasonably achievable) and that it be individualized to each patient, weighing the radiation exposure risk versus diagnostic testing benefit. Diagnostic radiation should only be prescribed when the benefits of a particular test are felt to outweigh any potential harm from the resulting radiation exposure. In addition, the SCCT recommends following the published guidelines and appropriate use criteria regarding indications for diagnostic and screening cardiac imaging studies.

Matthew Budoff, M.D., FSCCT, professor of medicine, Los Angeles Biomedical Research Institute, SCCT president adds, "We [SCCT] vigorously support awareness of radiation safety and the adoption of a policy of responsible diagnostic radiation use. We encourage ongoing efforts to continue the excellent work taking place in the area of diagnostic radiation reduction techniques and radiation exposure monitoring. We are encouraged that the increased awareness has led to improvements in patient dose. Most of our members have reported dose reductions up to 70 percent at their institutions for cardiac CT angiography."

For more information: www.SCCT.org

Related Content

St. Jude Medical, ADO II AS trial, congenital heart disease, PDA, Amplatzer Duct Occluder II AS
News | Congenital Heart| October 19, 2016
St. Jude Medical Inc. announced the launch of the ADO II AS (AMPLATZER Duct Occluder II Additional Sizes) pediatric...
Lantheus, flurpiridaz F-18, myocardial perfusion imaging, MPI, cardiac stress testing, ASNC 2016
News | Radiopharmaceuticals and Tracers| October 17, 2016
Lantheus Holdings Inc. announced in late September that sub-analysis data from the first Phase 3 study of flurpiridaz F...
Medtronic, FIRE AND ICE trial, Arctic Front, cryoballoon catheter ablation, radiofrequency RF ablation, study results, Asia Pacific Heart Rhythm Society Scientific Sessions
News | Ablation Systems| October 17, 2016
Medtronic plc last week unveiled new health economic analysis data from the FIRE AND ICE trial that favor cryoballoon...
Toshiba CT, picking a CT scanner, choosing a CT scanner, CT 101, what to look for in CT scanners, Aquilion ONE ViSION

The Toshiba Aquilion One Vision system is among the new generation of CT systems on the market that offers several dose lowering technologies and a hardware/software combination to enhance image quality over previous-generation scanners.

Feature | CT Angiography (CTA)| October 14, 2016 | Dave Fornell
As hospitals begin replacing their first-generation 64-slice computed tomography (CT) scanners after a decade of use,
transcarotid artery revascularization, TCAR Surveillance Project, Society for Vascular Surgery Patient Safety Organization, SVS PSO,
News | Stents Carotid| October 13, 2016
A surveillance project to evaluate the safety and effectiveness of transcarotid artery revascularization (TCAR) in...
Shockwave lithoplasty system, VIVA 16, Vascular Interventioanl Advances, VIA Physicians, late-breaking endovascular clinical trial results
News | Cath Lab| October 12, 2016
VIVA (Vascular Interventional Advances) Physicians announced a number of highly anticipated late-breaking clinical...
ZipLine Medical, Zip Surgical Skin Closure, cath lab time savings, PACE study
News | EP Lab| October 10, 2016
October 10, 2016 — ZipLine Medical Inc.
Mercator MedSystems, Bullfrog Micro-Infusion Device, DANCE trial, VIVA 2016, 13-month results
News | Peripheral Arterial Disease (PAD)| October 07, 2016
Mercator MedSystems recently announced that 13-month data from the DANCE trial was presented during a late-breaking...
Keystone Heart, TriGuard Embolic Protection Device, Neuro-TAVR study, brain lesions, American Journal of Cardiology
News | Heart Valve Technology| October 03, 2016
Keystone Heart Ltd. announced data recently published in the American Journal of Cardiology demonstrating new brain...
TCT 2016, TCT.16, main arena, late breaking trials
Feature | Cath Lab| September 28, 2016
September 28, 2016 — The Cardiovascular Research Foundation (CRF) has announced the 11 late-breaking trials and 16 fi
Overlay Init